Bio-Rad Laboratories (BIO) to Release Quarterly Earnings on Thursday

Bio-Rad Laboratories (NYSE:BIO) is expected to issue its quarterly earnings data after the market closes on Thursday, February 13th. Analysts expect the company to announce earnings of $2.86 per share and revenue of $679.75 million for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

Bio-Rad Laboratories Price Performance

BIO opened at $314.82 on Wednesday. Bio-Rad Laboratories has a 1 year low of $262.12 and a 1 year high of $387.99. The company has a debt-to-equity ratio of 0.16, a quick ratio of 4.52 and a current ratio of 6.14. The company’s 50 day simple moving average is $340.56 and its 200 day simple moving average is $336.91. The stock has a market capitalization of $8.81 billion, a PE ratio of -11.52 and a beta of 0.90.

Analyst Ratings Changes

Several brokerages have recently issued reports on BIO. StockNews.com raised shares of Bio-Rad Laboratories from a “hold” rating to a “buy” rating in a research note on Friday, November 1st. Citigroup boosted their target price on Bio-Rad Laboratories from $400.00 to $450.00 and gave the stock a “buy” rating in a report on Thursday, October 31st. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $481.00 price target on shares of Bio-Rad Laboratories in a report on Tuesday, January 14th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, Bio-Rad Laboratories currently has a consensus rating of “Moderate Buy” and a consensus price target of $394.20.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets.